SCHEMBL18558673

SCHEMBL18558673

Cc1cccc(C(=O)/N=C(\Nc2cc(-c3ccc(F)cc3)n[nH]2)NC(C)(C)C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
KMT2A Q03164 2/20 0.38
ALOX15 P16050 2/20 0.38
MEN1 O00255 1/20 0.38
ACR P10323 2/20 0.38
CA12 O43570 1/20 0.37
ALPL P05186 1/20 0.37
RPA1 P27694 1/20 0.37
CYP2C19 P33261 1/20 0.37
THRB P10828 1/20 0.36
HDAC3 O15379 2/20 0.36
HDAC4 P56524 2/20 0.36
HDAC1 Q13547 2/20 0.36
HDAC7 Q8WUI4 2/20 0.36
HDAC2 Q92769 2/20 0.36
HDAC10 Q969S8 2/20 0.36
HDAC11 Q96DB2 2/20 0.36
HDAC8 Q9BY41 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18558486 0.92 NPC1 (0.40) NPC1RAB9AACRCA12ALPL
SCHEMBL18558653 0.90 IDO1 (0.39) NPC1RAB9AACRCA12ALPL
SCHEMBL18558410 0.90 CA12 (0.37) NPC1RAB9AKMT2AALOX15MEN1
SCHEMBL18558676 0.89 MAPT (0.40) NPC1RAB9AKMT2AALOX15MEN1
SCHEMBL18558487 0.89 ALPL (0.42) SMN1; SMN2NPC1RAB9AACRCA12
SCHEMBL18558230 0.89 ADCY8 (0.42) KMT2AMEN1ACRCA12ALPL
SCHEMBL18556491 0.88 CA12 (0.35) SMN1; SMN2NPC1RAB9AACRCA12
SCHEMBL18558665 0.88 MAPT (0.48) SMN1; SMN2NPC1RAB9AKMT2AALOX15
SCHEMBL18558256 0.87 VNN1 (0.39) ACRCA12ALPLRPA1CYP2C19
SCHEMBL18557570 0.87 VNN1 (0.40) SMN1; SMN2ACRCA12ALPLRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9580388-B2 Pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2017-02-28 US disclosed